Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
epoetin beta
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase IV Randomized Study of Epoetin beta for Anemia Management in Patients With Stage IIB, III, or IVA Cervical Cancer Treated With Cisplatin and Radiotherapy
Phase:
Phase IV
Type:
Supportive care, Treatment
Status:
Completed
Age:
Over 18
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AGOSG-OVAR-MO16375-MARCH
, EU-20217, ROCHE-MO16375, ROCHE-RO2053859, NCT00046969
2.
A Study of the Management of Blood Loss in Patients Undergoing Surgical Removal of Tumors
Phase:
Phase IV
Type:
Supportive care, Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CR003460
, NCT00264095
3.
Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients
Phase:
Phase III
Type:
Supportive care, Treatment
Status:
Closed
Age:
20 to 79
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
EPO316 JP
, NCT00628043
4.
Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
61 to 75
Sponsor:
Other
Protocol IDs:
BACOPP-21
, NCT00284271
5.
Phase II Study of Epoetin beta for Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CHUL-NEOPALIA
, RECF0359, NEOPALIA, NCT00559195
6.
A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
ML20559
, NCT00551291
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute